Tempus AI (TEM) Protective Put Calculator

Calculator · free · no signup · TEM

Price a protective put or zero-cost collar on Tempus AI. Annual cost, max loss, upside cap, tax treatment, auto-filled from current TEM option chain.

Beta · invite-only · AlphaLatitude Inc. · Free Tools

You priced one hedge. The beta picks the right hedge structure given your full equity stack and tax situation.

Request beta access →

About Tempus AI

Tempus AI (TEM) is a public Data company, incorporated in Nevada and headquartered in Chicago, IL. IPO'd Jun 14, 2024.

Last close: $50.56 per share (as of 2026-06-16).

AI healthcare data.

Equity grants at Tempus AI typically include incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs).

Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."

Source: Wikipedia (CC BY-SA 4.0)

Eric Lefkofsky founded Tempus in Chicago in 2015 after his wife's breast cancer diagnosis exposed how little structured data oncologists could pull on demand. The platform now links clinical records with molecular sequencing across oncology, cardiology, and neuropsychiatry, and sells AI-enabled diagnostics back to physicians and pharma. Tempus listed on NASDAQ as TEM in June 2024 at $37. Revenue hit $1.27B in 2025 (up 83%), and a three-year AstraZeneca and Pathos collaboration adds $200M in data and model-development fees toward a multimodal oncology foundation model.

Sources: en.wikipedia.org · investors.tempus.com

Equity comp at Tempus AI

  • RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.

Researched 2026-05-07.

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Tempus AI.

A protective put caps your downside on the TEM position at a chosen floor; a zero-cost collar pays for that floor by capping the upside. This calculator prices both structures off the current TEM option chain, with annual cost, max loss, and tax-treatment notes.

Example: a 5,000-share TEM position at $50.56 is worth $252,800. A 1-year 30%-OTM put on that position typically runs 2-4% of position value per year (about $5,056 to $10,112) before any premium offset from a short call. The calculator prices both structures off TEM's current option chain so you see the actual cost for your chosen floor, tenor, and cap.

All Tempus AI tools → · Use the generic Protect Your Stock Calculator for any company.

Tempus AI equity questions

How much does it cost to hedge TEM stock?
The cost of a protective put depends on how far below the current price you set the floor, how long the protection lasts, and TEM's option-implied volatility. A zero-cost collar lowers that cost by selling away some upside. The calculator above prices both structures off the current TEM option chain and shows the annual cost, maximum loss, and tax treatment.
Does Tempus AI grant ISOs, NSOs, or RSUs?
Equity compensation at Tempus AI typically takes the form of incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs). Incentive stock options can trigger the alternative minimum tax (AMT) when you exercise. Restricted stock units are taxed as ordinary income when they vest.
Do Tempus AI RSUs use double-trigger vesting?
No. Tempus AI restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyData peers

One piece of the puzzle.

OptionsAhoy plans your Tempus AI equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access